Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma
Keywords:
Bruton tyrosine kinase (BTK)
Mantle cell lymphoma (MCL)
Acalabrutinib
Clinical data
Publisher:
Springer Science and Business Media LLC
Note:
This article is licensed under a Creative Commons Attribution 4.0 International License
Citation:
Wang, M. (Michael); Rule, S. (Simon); Zinzani, P.L. (P.L.); et al. "Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma". Leukemia. 33, 2019, 2762 - 2766
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.